v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Apr. 30, 2025
Jul. 31, 2024
Current assets    
Cash at banks $ 156,131 $ 434,351
Trade receivables, net of allowance for credit loss of $27,011 and $25,366 as of April 30, 2025 and July 31, 2024, respectively 11,229 10,964
Retention sum receivables 78,580 109,945
Other receivables, prepayments and deposits 44,959 12,801
Contract assets 284,949 269,434
Deferred cost 2,356 4,122
Total current assets 578,204 841,617
Non-current assets    
Plant and equipment, net 19,262 20,817
Lease right-of-use asset 40,445 59,197
Equity method investment
Total non-current assets 59,707 80,014
TOTAL ASSETS 637,911 921,631
Non-current liability    
Lease liabilities, non-current 8,619 31,553
Total non-current liabilities 8,619 31,553
Current liabilities    
Trade payables 108,416 81,466
Retention sum payables 70,652 67,697
Other payables and accrued liabilities (Included $77,870 due to related party) 101,224 34,386
Lease liabilities, current 33,040 29,469
Income tax payables 494
Total current liabilities 313,826 213,018
Total liabilities 322,445 244,571
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.0001 par value, 200,000,000 shares authorized; None issued and outstanding
Common stock, $0.0001 par value, 1,000,000,000 shares authorized 332,699,500 shares issued and outstanding as of April 30, 2025 and July 31, 2024 respectively 33,270 33,270
Additional paid-in capital 3,245,230 3,245,230
Accumulated other comprehensive loss (28,843) (14,009)
Accumulated deficit (2,934,191) (2,587,431)
Total stockholders’ equity 315,466 677,060
TOTAL LIABILITIES AND STOCKHOLDERS’ FUND $ 637,911 $ 921,631